Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Buy
7,189
+5,875
+447% +$1.02M 0.12% 139
2026
Q1
$222K Buy
1,314
+12
+0.9% +$2.3K 0.03% 393
2025
Q4
$245K Sell
1,302
-4,172
-76% -$786K 0.03% 376
2025
Q3
$1.12M Buy
5,474
+114
+2% +$24.3K 0.13% 144
2025
Q2
$1.19M Sell
5,360
-948
-15% -$204K 0.15% 112
2025
Q1
$1.3M Buy
6,308
+1,412
+29% +$281K 0.18% 98
2024
Q4
$894K Buy
+4,896
New +$1.03M 0.13% 133

Other funds holding CTAS

Novem Group's CTAS Position: Q2 2026 in Review

Novem Group increased its Cintas (CTAS) stake by 447% in Q2 2026, buying an estimated $1.02M and bringing the position to 7,189 shares worth $1.22M. The position accounts for 0.12% of the portfolio, ranked #139.

Novem Group first reported a position in CTAS in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.3M in Q1 2025. 1,422 funds tracked by Wall St. Rank hold CTAS as of Q2 2026.

  • Novem Group held 7,189 shares of Cintas worth $1.22M as of Q2 2026.
  • Novem Group bought 5,875 Cintas shares in Q2 2026, an estimated $1.02M.
  • Cintas made up 0.12% of Novem Group's portfolio in Q2 2026, its #139 holding.
  • Novem Group first reported a position in Cintas in Q4 2024 and has held it in 7 quarters since.
  • Novem Group's Cintas position peaked at $1.3M in Q1 2025.
  • 1,422 funds tracked by Wall St. Rank held Cintas as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.